Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

The recent earnings posted by Exchange Income Corporation ( TSE:EIF ) were solid, but the stock didn't move as much ...

The Treasury Stock Method provides valuable insights for investors by illustrating the potential dilution effect on a company’s EPS. This method is particularly useful for assessing the ...

Check out Equinox Gold's historical EPS growth by clicking on this link. A Look At The Impact Of Equinox Gold's Dilution On Its Earnings Per Share (EPS) As it happens, we don't know how much the ...

1,808 ($207/ $0.1145), which is about 13% higher than without the inclusion of dilutive shares. To put this huge P/E ratio of 1,592 into perspective, EPS would need to grow by 115% CAGR to get a P ...

Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.

Total U.S. GAAP diluted EPS includes ($0.95) from continuing operations and ($0.05) from discontinued operations. These results include special items totaling $908 million after-tax, primarily ...

Check out Equinox Gold's historical EPS growth by clicking on this link. A Look At The Impact Of Equinox Gold's Dilution On Its Earnings Per Share (EPS) As it happens, we don't know how much the ...